Drugs / AC-076
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03173625 | Nov 2016 → Apr 2017 | — | Viatris Innovation GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC-076 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03173625 ↗ |
| Route | Subcutaneous | “AC-076 administered as subcutaneous injection” NCT03173625 ↗ |